01 · The Goal

Regenerate the hormone-producing glands the body cannot replace on its own

The goal is to regenerate hormone-producing glands — regrowing the hormone-producing glands themselves. For a real person and the family beside them, this is the line between slow decline and getting their life back.

02 · Why It Matters

Hormones are the body’s chemical messengers, governing energy, growth, stress, and reproduction. When the glands that make them fail, the effects ripple through every system, and replacement is often crude and lifelong. Regenerating the glands themselves and restoring true hormonal balance would change diabetes, thyroid and adrenal disease, and the hormonal shifts of aging. When the messengers fail, energy, mood, and balance fail with them — restoring them restores the rhythm of daily life.

03 · What We’re Trying to Achieve

We are building the capability to regrow hormone-producing glands: from stem cells, engineered tissue, and the biology that drives true regeneration. The work runs from proven clinical care now to the frontier science still maturing — and this page marks exactly where each piece stands.

04 · How It Works

How it works

Stem-cell and tissue therapies Demonstrated in research

Lab-grown cells and tissue regrow structure in animal studies and early trials.

Engineered tissue Frontier

Building functional replacement tissue in the lab is an advancing frontier.

Regeneration in the body Frontier

Coaxing the body to regenerate the tissue itself is early-stage laboratory science.

Engineered tissue & integration Clinical

Building functional, blood-supplied replacement tissue — and getting it to integrate and last — is advancing from the lab toward the clinic.

05 · Who’s Building It

Cited as evidence the capability is real — not as partners or endorsers.

Government & programs

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) · NIH endocrinology programs. These public programs fund the foundational research that shows the capability is real.

Universities & institutes

Academic endocrinology and gland-regeneration research centers. Academic laboratories carry that science from discovery toward the clinic.

Enabling science base

endocrine-gland biology · hormone signaling · gland stem cells · closed-loop hormone control. — the established disciplines this capability is built upon.

06 · Technologies

The technologies: gland-regeneration biology, cell therapies for hormone-producing tissue, closed-loop hormone delivery, and the precise replacement medicine used today.

07 · Breakthroughs

Cell therapy Demonstrated

Cells regrow structure in research.

Engineered tissue Frontier

Replacement tissue is advancing in the lab.

In-body regeneration Frontier

Regenerating in place is early-stage.

From bench toward bedside Clinical trials

The first regenerative therapies have entered human trials — the transition from demonstrated regrowth toward real treatment.

08 · Remaining Challenges

The honest challenges: regrowing cells is increasingly possible; building functional, integrated, durable tissue in people is the largely frontier challenge. Regrowing cells is increasingly within reach; building functional, blood-supplied, lasting tissue inside a living person is the harder, largely frontier challenge — and the one the field is racing to solve. Every line here is tagged for its real stage, so what is demonstrated is never confused with what is deployed.

09 · Mature Capability

The future, fully built

Hormone-producing glands that the body cannot replace is regenerated — regrown, engineered, and restored — so loss becomes repairable. — staged plainly here, so the promise is always measured against the proof.

Honest boundary: each item is tagged for where it stands — demonstrated, clinical, or frontier. The science is real, funded, and accelerating. AI supports human clinicians; it never replaces them.
10 · Evidence Vault

The proof, for this capability

Cited as evidence the capability is real, not as partners or endorsers.

Cell therapy

Cells regrow structure in research and early trials. Stage: Demonstrated.

Engineered tissue

Replacement tissue is advancing. Stage: Frontier.

In-body regeneration

Regenerating in place is early-stage. Stage: Frontier.

Honest framing

Real organizations are cited as evidence the capability is real — not as partners or endorsers. Full functional regeneration in people is frontier and not claimed as routine.

Where it stands

Each line above is tagged for its stage — demonstrated, clinical, or frontier — so the page shows exactly how far the real science has come, and how far is left.

Help build this future

Every signature grows the movement to make endocrine-gland regeneration real — and free at the point of need.

Paid for by Michael Floyd for President.

Scroll to Top